GGrantIndex
Sort

261,768 grants matching gene therapy

From therapeutic mechanisms to unraveling the pathophysiology of MS

$2,696,244
Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Plasma Cells in Health and Disease

$2,695,938
Ignacio E. Sanz · Emory University · P01 · FY2022 · AI

Genetic variant-based drug discovery targeting conserved pathways of aging

$2,694,643
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2024 · AG

Disease mechanism and therapies for retinal degeneration

$2,694,416
Tiansen Li · National Eye Institute · ZIA · FY2023 · EY

SPORE in Prostate Cancer

$2,694,329
Michael M. Ittmann · Baylor College Of Medicine · P50 · FY2006 · CA

Mechanisms of sleep and sleep apnea

$2,693,865
Clifford B Saper · Beth Israel Deaconess Medical Center · P01 · FY2020 · HL

Plasma Cells in Health and Disease

$2,691,282
Ignacio E. Sanz · Emory University · P01 · FY2023 · AI

Mechanisms and Impact of NRG3 Induction in Bone Metastasis

$2,691,173
Igor Landry Bado · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)

$2,691,169
Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2024 · NS

Spore in Head and Neck Cancer

$2,691,110
David Sidransky · Johns Hopkins University · P50 · FY2010 · DE

Breast Cancer genetic study in African-ancestry populations

$2,690,408
Wei Zheng · Vanderbilt University Medical Center · R01 · FY2016 · CA

Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study

$2,690,282
Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2014 · HL

TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance

$2,689,988
Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE

Immunotherapy targeting the HPA axis in Alzheimer’s disease

$2,689,784
Todd E. Golde · University Of Florida · RF1 · FY2019 · AG

Center for Clinical and Translational Sciences (CCTS)

$2,689,467
David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2016 · TR

PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM

$2,689,144
Fred Hutchinson Cancer Research Center · P50 · FY2003 · CA

Development of rationally designed HIV vaccines

$2,689,105
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

GENERAL CLINICAL RESEARCH CENTER

$2,688,678
Yale University · M01 · FY2000 · RR

Pharmacogenomics of Statin Therapy

$2,688,571
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · P50 · FY2017 · GM

Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment

$2,688,227
Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC

BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENE

$2,688,107
Mount Sinai School Of Medicine Of Nyu · U01 · FY2001 · CA

GENE THERAPY FOR HEMOPHILIA AND CORONARY ARTERY DISEASE

$2,687,829
Stanford University · U01 · FY2004 · HL

Plasma Cells in Health and Disease

$2,686,806
Ignacio E. Sanz · Emory University · P01 · FY2024 · AI

Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression

$2,686,033
Josh Levitsky · Northwestern University At Chicago · U01 · FY2024 · AI

Mechanisms of Motor Control in the Spinal Cord

$2,686,023
Ariel Levine · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS